---
layout: post
title: "SHINE Medical Technologies, LLC; Medical Isotope Production Facility"
date: 2026-02-05 18:59:45 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-14384
original_published: 2022-07-08 00:00:00 +0000
significance: 8.00
---

# SHINE Medical Technologies, LLC; Medical Isotope Production Facility

**Published:** February 05, 2026 18:59 UTC
**Source:** Federal Register
**Original Published:** July 08, 2022 00:00 UTC
**Document Number:** 2022-14384

## Summary

The U.S. Nuclear Regulatory Commission (NRC) is issuing for public comment draft Supplement 1 to NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, issued October 2015. SHINE Medical Technologies, LLC (SHINE) is requesting a license to operate the Medical Isotope Production Facility (SHINE facility) in Janesville, Wisconsin. The NRC is seeking public comment on this action and has scheduled a public meeting that will take place as an online webinar and teleconference.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/07/08/2022-14384/shine-medical-technologies-llc-medical-isotope-production-facility)
- API: https://www.federalregister.gov/api/v1/documents/2022-14384

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
